Combining plasma p-Tau181 and p-Tau231 enhances Alzheimer's disease in vivo classification

被引：0
|
作者：
Ferreira, Pamela C. Lukasewicz [1 ]
Brum, Wagner S. [2 ]
Ferrari-Souza, Joao Pedro [1 ,2 ]
Tissot, Cecile [3 ]
Bellaver, Bruna [1 ,2 ]
Therriault, Joseph [3 ]
Ashton, Nicholas J. [4 ]
Benedet, Andrea L. [3 ,5 ]
Servaes, Stijn [3 ]
Lussier, Firoza Z. [3 ]
Chamoun, Mira [3 ]
Stevenson, Jenna [3 ]
Rahmouni, Nesrine [3 ]
Gauthier, Serge [3 ]
Vanmechelen, Eugeen [3 ]
Zetterberg, Henrik [4 ]
Blennow, Kaj [6 ]
Zimmer, Eduardo R. [2 ]
Karikari, Thomas [1 ,5 ]
Rosa-Neto, Pedro [3 ]
Pascoal, Tharick A. [1 ]
机构：
[1] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
[2] Univ Fed Rio Grande Sul UFRGS, Grad Program Biol Sci Biochem, Porto Alegre, RS, Brazil
[3] McGill Univ, Montreal, PQ, Canada
[4] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden
[5] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
[6] Sahlgrens Univ Hosp, Clin Neurochem Lab 11, Molndal, Sweden
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2021-112
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [21] Comparison of CSF and plasma p-tau181 concentrations in predicting clinical diagnosis of Alzheimer's disease
    Kumar, Pankaj
    Encarnacion, Mary
    Fok, Alice
    Mousavi, Ali
    Hsiung, Ging-Yuek Robin
    Frykman, Hans
    CLINICAL BIOCHEMISTRY, 2022, 109 : 118 - 118
  • [22] Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA
    Quaresima, Virginia
    Pilotto, Andrea
    Trasciatti, Chiara
    Tolassi, Chiara
    Parigi, Marta
    Bertoli, Diego
    Mordenti, Cristina
    Galli, Alice
    Rizzardi, Andrea
    Caratozzolo, Salvatore
    Benussi, Alberto
    Ashton, Nicholas J.
    Blennow, Kaj
    Zetterberg, Henrik
    Giliani, Silvia
    Brugnoni, Duilio
    Padovani, Alessandro
    NEUROBIOLOGY OF AGING, 2024, 143 : 30 - 40
  • [23] Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease
    Janelidze, Shorena
    Stomrud, Erik
    Smith, Ruben
    Palmqvist, Sebastian
    Mattsson, Niklas
    Airey, David C.
    Proctor, Nicholas K.
    Chai, Xiyun
    Shcherbinin, Sergey
    Sims, John R.
    Triana-Baltzer, Gallen
    Theunis, Clara
    Slemmon, Randy
    Mercken, Marc
    Kolb, Hartmuth
    Dage, Jeffrey L.
    Hansson, Oskar
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [24] Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
    Shorena Janelidze
    Erik Stomrud
    Ruben Smith
    Sebastian Palmqvist
    Niklas Mattsson
    David C. Airey
    Nicholas K. Proctor
    Xiyun Chai
    Sergey Shcherbinin
    John R. Sims
    Gallen Triana-Baltzer
    Clara Theunis
    Randy Slemmon
    Marc Mercken
    Hartmuth Kolb
    Jeffrey L. Dage
    Oskar Hansson
    Nature Communications, 11
  • [25] Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring
    Ashton, Nicholas J.
    Janelidze, Shorena
    Mattsson-Carlgren, Niklas
    Binette, Alexa Pichet
    Strandberg, Olof
    Brum, Wagner S.
    Karikari, Thomas K.
    Gonzalez-Ortiz, Fernando
    Di Molfetta, Guglielmo
    Meda, Francisco J.
    Jonaitis, Erin M.
    Koscik, Rebecca Langhough
    Cody, Karly
    Betthauser, Tobey J.
    Li, Yan
    Vanmechelen, Eugeen
    Palmqvist, Sebastian
    Stomrud, Erik
    Bateman, Randall J.
    Zetterberg, Henrik
    Johnson, Sterling C.
    Blennow, Kaj
    Hansson, Oskar
    NATURE MEDICINE, 2022, 28 (12) : 2555 - +
  • [26] Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology
    Asken, Breton M.
    Tanner, Jeremy A.
    VandeVrede, Lawren
    Mantyh, William G.
    Casaletto, Kaitlin B.
    Staffaroni, Adam M.
    La Joie, Renaud
    Iaccarino, Leonardo
    Soleimani-Meigooni, David
    Rojas, Julio C.
    Gardner, Raquel C.
    Miller, Bruce L.
    Grinberg, Lea T.
    Boxer, Adam L.
    Kramer, Joel H.
    Rabinovici, Gil D.
    NEUROLOGY, 2022, 99 (06) : E594 - E604
  • [27] CSF p-tau231: A biomarker for early preclinical Alzheimer?
    Suarez-Calvet, Marc
    EBIOMEDICINE, 2022, 77
  • [28] Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
    Nicholas J. Ashton
    Shorena Janelidze
    Niklas Mattsson-Carlgren
    Alexa Pichet Binette
    Olof Strandberg
    Wagner S. Brum
    Thomas K. Karikari
    Fernándo González-Ortiz
    Guglielmo Di Molfetta
    Francisco J. Meda
    Erin M. Jonaitis
    Rebecca Langhough Koscik
    Karly Cody
    Tobey J. Betthauser
    Yan Li
    Eugeen Vanmechelen
    Sebastian Palmqvist
    Erik Stomrud
    Randall J. Bateman
    Henrik Zetterberg
    Sterling C. Johnson
    Kaj Blennow
    Oskar Hansson
    Nature Medicine, 2022, 28 : 2555 - 2562
  • [29] Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau
    Frank, Brandon
    Ally, Madeline
    Brekke, Bailee
    Zetterberg, Henrik
    Blennow, Kaj
    Sugarman, Michael A.
    Ashton, Nicholas J.
    Karikari, Thomas K.
    Tripodis, Yorghos
    Martin, Brett
    Palmisano, Joseph N.
    Steinberg, Eric G.
    Simkina, Irene
    Turk, Katherine W.
    Budson, Andrew E.
    O'Connor, Maureen K.
    Au, Rhoda
    Goldstein, Lee E.
    Jun, Gyungah R.
    Kowall, Neil W.
    Stein, Thor D.
    McKee, Ann C.
    Killiany, Ronald
    Qiu, Wei Qiao
    Stern, Robert A.
    Mez, Jesse
    Alosco, Michael L.
    ALZHEIMERS & DEMENTIA, 2022, 18 (08) : 1523 - 1536
  • [30] Evaluating p-tau217 and p-tau231 as Biomarkers for Early Diagnosis and Differentiation of Alzheimer's Disease: A Narrative Review
    Jarek, Dorian Julian
    Mizerka, Hubert
    Nuszkiewicz, Jaroslaw
    Szewczyk-Golec, Karolina
    BIOMEDICINES, 2024, 12 (04)
12345